Mitchell Kapoor
Recent Articles about ChromaDex Corp.
LA Biotech Unveils New Patented Nicotinamide Riboside Chloride 07/15/2024
"The advent of NIAGEN IV could usher in a powerful new tailwind for revenue growth at ChromaDex Corp. (CDXC:NASDAQ)," noted an H.C. Wainwright & Co. report.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
